-
Je něco špatně v tomto záznamu ?
The use of pacemaker diagnostics for supporting the anticoagulation treatment management
David Korpas, Michaela Tanzerová
Jazyk angličtina Země Česko
Typ dokumentu klinická studie
- MeSH
- antikoagulancia farmakologie terapeutické užití MeSH
- fibrilace síní * komplikace patofyziologie terapie MeSH
- kardiostimulátor MeSH
- klinická studie jako téma MeSH
- lidé MeSH
- tromboembolie diagnóza komplikace krev terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- klinická studie MeSH
In this work, the analysis of data on atrial fibrillation (AF) burden from dual chamber pacemakers is used for supporting the anticoagulation treatment management. The aim is to evaluate the benefit of basic diagnostic functions to support oral anticoagulation therapy in patients with atrial fibrillation. These patients have increased risk of thromboembolism. If patients have an implanted pacemaker, the device’s diagnostic features monitor the frequency and duration of atrial fibrillation episodes. This data can then be used for further decisions. Statistical data processing was performed on a group of 117 patients with an implanted dual chamber pacemaker. From these results, we evaluated the benefits of the algorithms. In the whole group, a trend was observed in increase of the AF burden between the two monitored periods. The increase of AF burden occurred in 17 patients, while the decrease occurred in 6 patients only. Using simple logic functions, the numbers of patients with different binary values of the presence of AF, the presence of oral anticoagulation therapy, the risk CHA2DS2-VASc score and the values of AF burden were determined. Thus, in the whole group of patients, the diagnostic functions of the implanted devices contributed to the change in oral anticoagulation therapy for 24% of patients.
Institute for Clinical and Experimental Medicine Prague Czech Republic
Institute of Nursing Faculty of Public Policies Silesian University Opava Czech Republic
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23006604
- 003
- CZ-PrNML
- 005
- 20231006165045.0
- 007
- ta
- 008
- 230517s2020 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14311/CTJ.2020.4.04 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Korpas, David $7 xx0034427 $u Institute of Nursing, Faculty of Public Policies, Silesian University, Opava, Czech Republic
- 245 14
- $a The use of pacemaker diagnostics for supporting the anticoagulation treatment management / $c David Korpas, Michaela Tanzerová
- 504 __
- $a Literatura
- 520 9_
- $a In this work, the analysis of data on atrial fibrillation (AF) burden from dual chamber pacemakers is used for supporting the anticoagulation treatment management. The aim is to evaluate the benefit of basic diagnostic functions to support oral anticoagulation therapy in patients with atrial fibrillation. These patients have increased risk of thromboembolism. If patients have an implanted pacemaker, the device’s diagnostic features monitor the frequency and duration of atrial fibrillation episodes. This data can then be used for further decisions. Statistical data processing was performed on a group of 117 patients with an implanted dual chamber pacemaker. From these results, we evaluated the benefits of the algorithms. In the whole group, a trend was observed in increase of the AF burden between the two monitored periods. The increase of AF burden occurred in 17 patients, while the decrease occurred in 6 patients only. Using simple logic functions, the numbers of patients with different binary values of the presence of AF, the presence of oral anticoagulation therapy, the risk CHA2DS2-VASc score and the values of AF burden were determined. Thus, in the whole group of patients, the diagnostic functions of the implanted devices contributed to the change in oral anticoagulation therapy for 24% of patients.
- 650 17
- $a fibrilace síní $x komplikace $x patofyziologie $x terapie $7 D001281 $2 czmesh
- 650 _7
- $a tromboembolie $x diagnóza $x komplikace $x krev $x terapie $7 D013923 $2 czmesh
- 650 _7
- $a kardiostimulátor $7 D010138 $2 czmesh
- 650 _7
- $a antikoagulancia $x farmakologie $x terapeutické užití $7 D000925 $2 czmesh
- 650 _7
- $a klinická studie jako téma $7 D000068456 $2 czmesh
- 650 _7
- $a lidé $7 D006801 $2 czmesh
- 655 _7
- $a klinická studie $7 D000068397 $2 czmesh
- 700 1_
- $a Tanzerová, Michaela $7 xx0301706 $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
- 773 0_
- $t Lékař a technika $x 0301-5491 $g Roč. 50, č. 4 (2020), s. 142-145 $w MED00011033
- 910 __
- $a ABA008 $b B 1367 $c 1071 b $y p $z 0
- 990 __
- $a 20230517141648 $b ABA008
- 991 __
- $a 20231006165039 $b ABA008
- 999 __
- $a ok $b bmc $g 1933663 $s 1192826
- BAS __
- $a 3
- BMC __
- $a 2020 $b 50 $c 4 $d 142-145 $i 0301-5491 $m Lékař a technika $n Lék. tech. $x MED00011033
- LZP __
- $c NLK197 $d 20231006 $a NLK 2023-16/kv